NT

Nitin Tomar

Active Director Director DIN 09420531
DIN 09420531 First appointment Dec 2021 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Dec 2021
Shareholding value Locked Premium profile

About Nitin Tomar

Nitin Tomar has 4 years in corporate governance. Holds Director role. Currently with 1 company, including Ameo Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09420531
Primary Designation Director
First Appointment 01 Dec 2021
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedStatus
Ameo Pharma Private Limited U24110DL2020PTC362452
Director01 Dec 20212020Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ameo Pharma Private Limited
Premium access

Shareholding and investment profile for Nitin Tomar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nitin Tomar

Nitin Tomar has 4 years in corporate governance. Holds Director role. Currently with 1 company, including Ameo Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Nitin Tomar is associated with 1 company as Director.

Nitin Tomar has expertise in General Business.

Nitin Tomar has 4 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available